These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 46950)

  • 1. Letter: Metiamide in Zollinger-Ellison syndrome.
    Halloran LG; Swank M; Haynes BW
    Lancet; 1975 Feb; 1(7901):281. PubMed ID: 46950
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Metiamide in Zollinger-Ellison syndrome.
    Thompson MH; Vanables CW; Miller IT; Reed JD; Sanders DJ; Grund ER; Blair EL
    Lancet; 1975 Jan; 1(7897):35-6. PubMed ID: 46947
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Metiamide in Zollinger-Ellison syndrome.
    Sullivan SN
    Lancet; 1975 Mar; 1(7905):516. PubMed ID: 46977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Treatment of Zollinger-Ellison syndromes with metiamide or cimetidine. Potential risk of hyperimmunization manifestations].
    Moulias R; Congy F
    Nouv Presse Med; 1976 Jan; 5(3):149-50. PubMed ID: 4772
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.
    Richardson CT; Walsh JH
    N Engl J Med; 1976 Jan; 294(3):133-5. PubMed ID: 616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine.
    Burland WL; Sharpe PC; Colin-Jones DG; Turnbull PR; Bowskill P
    Lancet; 1975 Nov; 2(7944):1085. PubMed ID: 53565
    [No Abstract]   [Full Text] [Related]  

  • 7. Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.
    Mainardi M; Maxwell V; Sturdevant RA; Isenberg JI
    N Engl J Med; 1974 Aug; 291(8):373-6. PubMed ID: 4152590
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide.
    Milton-Thompson GJ; Williams JG; Jenkins DJ; Misiewicz JJ
    Lancet; 1974 Apr; 1(7860):693-4. PubMed ID: 4132419
    [No Abstract]   [Full Text] [Related]  

  • 9. [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors].
    Bonfils S; Bernier JJ; Mignon M; Hautefeuille P; Corbic M; Marteau J
    Nouv Presse Med; 1975 Oct; 4(33):2377-81. PubMed ID: 653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Neutropenia associated with metiamide.
    Forrest JA; Shearman DJ; Spence R; Celestin LR
    Lancet; 1975 Feb; 1(7903):392-3. PubMed ID: 46534
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology and toxicology of metiamide, a histamine H2-receptor antagonist.
    Brimblecombe RW; Duncan WA; Parsons ME
    S Afr Med J; 1974 Nov; 48(54):2253-5. PubMed ID: 4154511
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with H2 receptor antagonists. Zollinger-Ellison Syndrome.
    Siepler JK; Donahue P; Campagna K; Bombeck CT
    IMJ Ill Med J; 1978 Apr; 153(4):283-7. PubMed ID: 25249
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: H2-receptor antagonists for Z-E syndrome.
    Shumaker JB
    N Engl J Med; 1976 Apr; 294(18):1010-11. PubMed ID: 1256502
    [No Abstract]   [Full Text] [Related]  

  • 14. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral metiamide as an effective inhibitor of gastric acid secretion in man.
    Barbezat GO; Bank S; Clain J; Novis B; Marks IN
    S Afr Med J; 1974 Oct; 48(48):2018-20. PubMed ID: 4155128
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Accary JP
    Nouv Presse Med; 1974 Sep; 3(30):1883. PubMed ID: 4154029
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
    Mignon M; Galmiche JP; Bonfils S
    Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
    [No Abstract]   [Full Text] [Related]  

  • 19. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
    Digestion; 1977; 15(1):43-52. PubMed ID: 838177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of metiamide in the preoperative management of the Zollinger-El.
    Smith ER; Cuthbert JA; McKessar JH; Francis PN; Little JM
    Med J Aust; 1976 Jun; 1(26):1000-1. PubMed ID: 979765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.